Isosorbide side effects and hair loss is a concern raised by some patients taking this nitrate medication for angina or heart failure. Isosorbide mononitrate and isosorbide dinitrate are widely prescribed across the UK, working by dilating blood vessels to reduce the heart's workload. Whilst headache, dizziness, and flushing are well-recognised adverse effects, the question of whether isosorbide causes hair loss is less straightforward. This article examines what UK regulatory sources say, explores the evidence, and explains when to seek advice from your GP or pharmacist.

Common and Uncommon Side Effects of Isosorbide

The most common side effects of isosorbide are headache, dizziness, flushing, nausea, and palpitations, all caused by its vasodilatory mechanism. Isosorbide must never be taken with PDE5 inhibitors such as sildenafil, vardenafil, or tadalafil due to the risk of severe hypotension.

Experiencing these side effects? Our pharmacists can help you navigate them →

Isosorbide is a nitrate medication available in two principal forms: isosorbide mononitrate and isosorbide dinitrate. Both are widely prescribed in the UK for the prevention and treatment of angina pectoris, and occasionally in the management of heart failure. They work by releasing nitric oxide, which causes relaxation and dilation of blood vessels, reducing the workload on the heart and improving blood flow to the myocardium.

The most frequently reported side effects are directly related to this vasodilatory mechanism. Based on the Summary of Product Characteristics (SmPC) documents held on the Electronic Medicines Compendium (EMC) and the BNF, recognised adverse effects include:

• Headache (very common) — often described as throbbing and typically most pronounced when treatment begins

• Dizziness or light-headedness (common) — especially upon standing, due to a drop in blood pressure (postural hypotension)

• Flushing (common) — a sensation of warmth or redness, particularly affecting the face and neck

• Nausea or vomiting (common) — which may accompany headaches in some patients

• Tachycardia or palpitations (common) — a reflex increase in heart rate in response to vasodilation

These effects are generally dose-dependent and tend to diminish as the body adjusts to the medication over the first few weeks of treatment. Less commonly, patients may experience hypotension, syncope, or skin reactions such as rash.

Important safety information — PDE5 inhibitors: Isosorbide and all nitrate medicines must not be taken with phosphodiesterase-5 (PDE5) inhibitors used for erectile dysfunction or pulmonary hypertension — including sildenafil (Viagra), vardenafil, and tadalafil. Combining these medicines can cause a sudden, severe and potentially life-threatening drop in blood pressure. The BNF and UK SmPCs advise that nitrates should not be used within 24 hours of sildenafil or vardenafil, or within 48 hours of tadalafil. Patients should always inform their GP and pharmacist if they are taking or considering any of these medicines.

The MHRA and the EMC SmPCs for isosorbide mononitrate and isosorbide dinitrate list all recognised adverse effects. Patients are advised to read the patient information leaflet supplied with their medication and to report any unexpected or persistent symptoms to their GP or pharmacist promptly.

Is Hair Loss a Recognised Side Effect of Isosorbide?

Hair loss is not a recognised side effect of isosorbide mononitrate or isosorbide dinitrate in current UK SmPCs or BNF monographs. Alternative causes — including thyroid dysfunction, iron deficiency, or co-prescribed cardiovascular medicines — should be investigated by a GP.

Not sure if this is normal? Chat with one of our pharmacists →

Hair loss, or alopecia, is not listed as a recognised or established side effect of isosorbide mononitrate or isosorbide dinitrate in the current UK SmPCs held on the Electronic Medicines Compendium (EMC), nor in the BNF monographs for these medicines. This is an important distinction for patients who may be concerned after noticing changes in their hair whilst taking this medication.

That said, it is not uncommon for patients to associate new symptoms with a recently started or long-term medication, particularly when other explanations are not immediately apparent. Hair loss has many potential causes, including:

• Telogen effluvium — a temporary shedding triggered by physical or emotional stress, illness, or significant physiological change

• Nutritional deficiencies — such as iron deficiency (low ferritin) or vitamin D deficiency, which are routinely checked in UK primary care

• Thyroid dysfunction — both hypothyroidism and hyperthyroidism can cause diffuse hair thinning

• Androgenetic alopecia — the most common form of hair loss in both men and women

• Other medications — including beta-blockers, anticoagulants (such as heparin and warfarin), and some statins, which are frequently co-prescribed in patients with cardiovascular conditions and have a recognised association with hair loss in the BNF

Routine testing for zinc deficiency is not generally indicated in UK primary care unless there is a specific clinical reason to suspect it; a GP will usually prioritise a full blood count, ferritin, and thyroid-stimulating hormone (TSH) when investigating hair loss.

Given that isosorbide is typically prescribed to patients who may already be taking multiple medications for cardiovascular disease, it is important not to assume a causal link without proper clinical evaluation. There is no established link between isosorbide and hair loss based on current UK regulatory data, and patients should be encouraged to discuss any concerns with their healthcare provider rather than discontinuing their medication independently. Further information on the differential diagnosis of hair loss is available via NICE Clinical Knowledge Summaries (CKS) on alopecia and the NHS website.

What the Evidence Says About Nitrates and Hair Loss

Current clinical and pharmacological evidence does not support a causal link between nitrate medicines, including isosorbide, and alopecia. MHRA pharmacovigilance data has not established a recognised signal connecting nitrates with hair loss.

A review of the available clinical and pharmacological literature does not support a direct causal relationship between nitrate medicines, including isosorbide mononitrate and isosorbide dinitrate, and the development of alopecia. Nitric oxide, the active mediator released by these drugs, plays a complex role in hair follicle biology. Some preclinical and experimental research has explored the potential of nitric oxide donors in modulating hair follicle cycling and dermal papilla cell activity; however, this research remains at an early, experimental stage and has not translated into any established clinical guidance or recommendation.

Interestingly, topical minoxidil — one of the most widely used treatments for androgenetic alopecia — is itself a vasodilator with mechanisms that share some pharmacological similarities with nitrates, though the two drug classes are structurally and clinically distinct. This further underscores that vasodilation per se is not associated with hair loss.

The MHRA's pharmacovigilance activities, including analysis of spontaneous adverse event reports, have not established a recognised signal linking nitrate medicines with alopecia. Whilst individual case reports of hair loss in patients taking nitrates may exist within reporting databases such as the Yellow Card scheme, the presence of a report does not establish causation. Confounding factors — such as concurrent medications, underlying illness, nutritional status, and age — make it difficult to attribute hair loss to isosorbide specifically. At present, the weight of evidence does not support isosorbide as a cause of hair loss, and clinicians should explore alternative explanations when a patient presents with this concern.

When to Speak to Your GP or Pharmacist

Patients should contact their GP if they notice sudden or significant hair shedding, patchy hair loss, or hair loss accompanied by symptoms such as fatigue or cold intolerance. Isosorbide should never be stopped without medical advice, as abrupt withdrawal can cause rebound angina.

Patients taking isosorbide should feel empowered to raise any new or unexpected symptoms with their GP or pharmacist, including concerns about hair loss. Whilst hair thinning is unlikely to be directly caused by isosorbide, it may signal an underlying condition that warrants investigation, particularly in the context of cardiovascular disease management where multiple health factors are at play.

You should contact your GP or pharmacist if you notice:

• Sudden or significant hair shedding that is new or worsening

• Patchy hair loss rather than diffuse thinning, which may suggest alopecia areata or another dermatological condition

• Hair loss accompanied by other symptoms such as fatigue, weight changes, cold intolerance, or skin changes — which could indicate thyroid dysfunction

• Severe or persistent headaches, dizziness, or fainting related to your isosorbide dose

• Any new skin reactions, including rash or itching

Urgent advice — chest pain: If you experience chest pain that is severe, feels different from your usual angina, or is not relieved by glyceryl trinitrate (GTN) after three doses or within 15 minutes, call 999 immediately. Do not wait. If you experience severe dizziness, fainting, or feel unwell and are unsure whether you need emergency care, contact NHS 111.

It is particularly important that patients do not stop taking isosorbide without medical advice. Abrupt discontinuation of nitrate therapy can lead to rebound angina, which may be dangerous. If you suspect your medication is causing a side effect, your GP can review your treatment, consider dose adjustment, or investigate alternative causes of your symptoms. Pharmacists are also an accessible first point of contact and can advise on whether a GP appointment is necessary.

Any suspected adverse drug reactions can be reported directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Reporting helps the MHRA monitor the safety of medicines used in the UK.

Managing Side Effects While Taking Isosorbide

Most isosorbide side effects are manageable and improve over time; paracetamol is the preferred analgesic for nitrate headaches, and rising slowly helps reduce postural dizziness. A GP can arrange blood tests for thyroid function, ferritin, and full blood count if hair loss is a concern.

For the majority of patients, the side effects of isosorbide are manageable and tend to improve with time. Understanding how to minimise discomfort can help patients remain adherent to their treatment, which is essential for effective angina management.

For headaches, which are the most commonly reported side effect:

• Simple analgesics such as paracetamol may be taken and are the preferred first choice

• If you are considering ibuprofen or another non-steroidal anti-inflammatory drug (NSAID), speak to your GP or pharmacist first; NSAIDs are not specifically contraindicated with nitrates, but they may not be suitable for patients with cardiovascular or gastrointestinal conditions and should only be used on clinical advice

• Headaches often reduce in frequency and severity after the first one to two weeks of treatment

• Starting at a lower dose and gradually titrating upward, under medical supervision, can help

For dizziness and postural hypotension:

• Rising slowly from sitting or lying positions can reduce the risk of light-headedness

• Avoiding alcohol is advisable, as it can potentiate the blood pressure-lowering effect of nitrates

• Other medicines that lower blood pressure — including antihypertensives and some other cardiovascular drugs — can have an additive effect when taken alongside nitrates; your GP or pharmacist can advise on this

• Patients should be cautious when driving or operating machinery if dizziness is a problem

Reminder — PDE5 inhibitors: As noted above, medicines for erectile dysfunction or pulmonary hypertension (sildenafil, vardenafil, tadalafil) must not be taken with isosorbide or any nitrate. If you have been prescribed one of these medicines, inform your GP or cardiologist before taking it alongside isosorbide.

If hair loss is a concern, a GP may arrange blood tests to check thyroid function (TSH), full blood count, and ferritin, as these are common and treatable causes of hair thinning. A medication review may also be appropriate to assess whether any co-prescribed drugs are more likely contributors. Maintaining a balanced diet, managing stress, and avoiding harsh hair treatments can support overall hair health during this period.

Alternative Treatments and NICE Guidance on Nitrates

NICE guideline CG126 recommends long-acting nitrates such as isosorbide mononitrate for angina prophylaxis, with alternatives including beta-blockers, calcium channel blockers, and ivabradine if side effects are intolerable. A nitrate-free interval of eight to twelve hours daily is recommended to prevent nitrate tolerance.

NICE guidance on the management of stable angina (CG126), supported by NICE Clinical Knowledge Summaries (CKS) on angina, recommends that nitrates — including isosorbide mononitrate and isosorbide dinitrate — are used as part of a broader treatment strategy. Short-acting sublingual glyceryl trinitrate (GTN) is typically the first-line agent for acute angina relief, whilst long-acting nitrates such as isosorbide mononitrate are used for prophylaxis. NICE advises that patients should be offered a choice of anti-anginal therapies based on individual clinical circumstances, tolerability, and patient preference.

In heart failure, isosorbide dinitrate in combination with hydralazine may be considered for patients who cannot tolerate an ACE inhibitor or angiotensin receptor blocker (ARB), in line with NICE guideline NG106 on chronic heart failure in adults.

If a patient experiences intolerable side effects from isosorbide, several alternative or adjunctive treatments may be considered by their cardiologist or GP:

• Beta-blockers (e.g., bisoprolol, atenolol) — first-line agents for angina prophylaxis that reduce heart rate and myocardial oxygen demand

• Calcium channel blockers (e.g., amlodipine, diltiazem) — an alternative or addition to beta-blockers

• Ivabradine — for patients in sinus rhythm who cannot tolerate beta-blockers

• Nicorandil or ranolazine — second-line options for refractory angina

Nitrate tolerance — a reduction in efficacy with continuous use — is a recognised phenomenon. The BNF and UK SmPCs recommend a nitrate-free interval of approximately eight to twelve hours daily to maintain effectiveness, typically achieved through asymmetric dosing schedules (e.g., taking modified-release isosorbide mononitrate once in the morning, or spacing immediate-release doses unevenly). Patients should follow the dosing schedule prescribed and not adjust it without advice.

Patients concerned about side effects, including hair loss, should not self-discontinue isosorbide. Instead, a structured medication review with their GP or cardiologist is the appropriate pathway. Any changes to angina management should be guided by clinical assessment and aligned with current NICE recommendations to ensure patient safety and optimal cardiovascular outcomes.

Frequently Asked Questions